Autopsy report · NCT03913130

Extension Study to Study PQ-110-001 (NCT03140969)

“Terminated \[Study prematurely terminated due to sponsor decision for reasons unrelated to safety\]”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 3 years 5 months before it stopped.
• 9 participants enrolled.
• Results were posted on the registry 3 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 1, Phase 2

Sponsor

Laboratoires Thea

Sponsor type

Industry

Conditions

Leber Congenital Amaurosis 10; Blindness; Leber Congenital Amaurosis; Vision Disorders; Sensation Disorders; Neurologic Manifestations

Interventions

QR-110

Participants

9

Sites

3

Countries

Belgium, United States

Trials that died the same way

• Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
  “Study terminated at Sponsor's request.” (84% match in meaning)
• Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver
  “Study was terminated due to safety reason.” (83% match in meaning)
• Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Liver Transplant Patients
  “Study terminated by the Sponsor” (83% match in meaning)
• Pivotal Clinical Study of Endoscopic Ablation for Atrial Fibrillation (AF) in Patients That Have Failed Drugs
  “Study terminated based on decision of Sponsor.” (83% match in meaning)
• Phase I Study of WX-037 Alone and in Combination With WX-554 in Solid Tumours
  “Study terminated for business reasons” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.